Compared with the previous studies [3–5], the advantages of the present meta-analysis are as follows: First, this meta-analysis evaluated the diagnostic performance of DCP + AFP, whereas the previous meta-analyses focused on multiple serum biomarkers for HCC. This evidence concerns the gene AFP and hepatocellular carcinoma.